Literature DB >> 28150012

[A submandibular tumor].

C Breunig1, S Lodes2, Ph Benter3, B Fleige4, W Flügel2, M Bloching2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28150012     DOI： 10.1007/s00106-016-0328-2

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  5 in total

Review 1.  The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management.

Authors:  Rachna Madan; Jey-Hsin Chen; Beatrice Trotman-Dickenson; Francine Jacobson; Andetta Hunsaker
Journal:  Eur J Radiol       Date:  2010-07-18       Impact factor: 3.528

Review 2.  Surgery in Castleman's disease: a systematic review of 404 published cases.

Authors:  Nadia Talat; Ajay P Belgaumkar; Klaus-Martin Schulte
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

3.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Authors:  M Q Du; H Liu; T C Diss; H Ye; R A Hamoudi; N Dupin; V Meignin; E Oksenhendler; C Boshoff; P G Isaacson
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.